While ERα signalling has a key role in stimulating initial breast cancer cell proliferation during tumourigenesis, the expression of ERα is also an indication of a good outcome in breast cancer patients as ERα-positive patients can often be treated with endocrine therapy.33 Another OTUB1 target in breast cancer is the tumour suppressor p53. Here, OTUB1 is linked to breast cancer.